Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Ibuprofen vs Acetaminophen for Post-operative Pain Following Cholecystectomy
NCT06478758Phase 4
Key facts
- Status
- Completed
- Start
- Feb 2024
- Primary completion
- Apr 2024
- Countries
- 1
- Sponsor
- Giresun University
- Modality
- Small Molecules
- Drugs
- ibuprofen
- Conditions
- acute postoperative pain
01
Overview
Phase 4, randomised trial of ibuprofen in acute postoperative pain (2 arms), sponsored by Giresun University. Primary endpoint: Visual Analog Scale Score at 24 hours. Started Feb 2024; status: completed.
02
Design
2 arms- Study design
- Randomized
Ibuprofen Group
IV Ibuprofen 800 mg at end of surgery + standard post-op care
Acetaminophen Group
IV Acetaminophen 1000 mg at end of surgery + standard post-op care
03
Who it enrols
Adult patients (18-65 years) with ASA grade I-II undergoing laparoscopic cholecystectomy. Excludes patients with renal, hepatic, or GI disease, diabetes, bleeding disorders, pregnancy/breastfeeding, or recent long-term NSAID/opioid use.
04
Endpoints
Primary
Visual Analog Scale Score
Secondary
Opioid Consumption
Length of Hospital Stay
Beyond the preview
Go deeper on NCT06478758.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06478758.